NSPR InspireMD, Inc. Full Business Value
InspireMD, Inc. (NSPR) produces specialized carotid artery stents, leveraging the engineering expertise of its Israeli leadership and a transparent US expansion strategy. This chart reflects a price trend, where the Enterprise Value stands at -6.25, alongside chip shortage risks and logistical complexities amid global conflicts. Meanwhile, InspireMD, Inc. (NSPR) is benefiting from the rise in elective surgeries in Europe, increasing sales despite macroeconomic headwinds.
Financial and market metric breakdowns for InspireMD, Inc. (NSPR)
InspireMD, Inc. (NSPR) is developing the innovative CGuard system to minimize embolism risks during carotid artery surgeries. An analysis of the enterprise value metric allows for the determination of the actual cost of business acquisition. This metric sums the market capitalization with total debt, subtracting existing cash reserves. This process strips the asset's value of the influence of liquidity and leverage. The indicator's trend determines the fairness of the current price relative to the company's long-term potential.